Naoki Morimoto

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 2

Top Topics

Pulmonary Artery

Hepatitis C Virus Infection

Ejection Fraction

Top Venues

Hepatology research : the official journal of the Japan Society of Hepatology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, Tomomi Okubo, Norio Itokawa, Yuki Haga, Yuya Seko, Michihisa Moriguchi, Shunji Watanabe, Yuki Shiko, Hirokazu Takatsuka, Hiroaki Kanzaki, Keisuke Koroki, Masanori Inoue, Masato Nakamura, Soichiro Kiyono, Naoya Kanogawa, Takayuki Kondo, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Yosuke Inaba, Masafumi Ikeda, Shinichiro Okabe, Naoki Morimoto, Yoshito Itoh, Kazuyoshi Nakamura, Kenji Ito, Ryosaku Azemoto, Masanori Atsukawa, Ei Itobayashi, Naoya Kato
A prospective study exploring the safety and efficacy of lenvatinib for patients with advanced hepatocellular carcinoma and high tumor burden: The LAUNCH study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yoshinari Takaoka, Kouichi Miura, Naoki Morimoto, Tadashi Ikegami, Satoru Kakizaki, Ken Sato, Takashi Ueno, Atsushi Naganuma, Takashi Kosone, Hirotaka Arai, Takeshi Hatanaka, Toshiyuki Tahara, Shigeo Tano, Takaaki Ohtake, Toshimitsu Murohisa, Masashi Namikawa, Takeharu Asano, Toshiro Kamoshida, Katsuhiko Horiuchi, Takeshi Nihei, Atsuko Soeda, Hidekazu Kurata, Takeshi Fujieda, Toshiya Ohtake, Yukimura Fukaya, Makoto Iijima, Shunji Watanabe, Norio Isoda, Hironori Yamamoto, null null
Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection. Hepatology research : the official journal of the Japan Society of Hepatology 51 (1) (2020)